TABLE 4.
Patient | Origin | Strain | Fluconazole MIC (μg/ml) | MTL | Plasmid name | EcoRI profile | AciI profile | Sequence profilec | One-hybrid phenotypee | TAC1 GOF mutation(s) |
---|---|---|---|---|---|---|---|---|---|---|
A | CHUVd | DSY281 | 1 | a/α | 1607-1 | A | WT | |||
1607-2 | B | WT | ||||||||
DSY284 | 32 | a/α | 1608-8 | A | Allele A | HYP | H741Ya | |||
1608-99 | A | Allele B | HYP | G980E + H741Y | ||||||
B | DSY2014 | 0.125 | a/α | 1609-13 | A | WT | ||||
1609-12 | B | WT | ||||||||
DSY2015 | 16 | a/α | 1621-71b | A | HYP | R673Q | ||||
C | DSY2019 | 4 | α/α | 1610-19 | A | WT | ||||
1610-16 | B | HYP | N972D | |||||||
DSY2020 | 32 | α/α | 1622-76 | B | HYP | N972D | ||||
D | DSY2250 | 1 | a/α | 1611-23 | A | WT | ||||
1611-24 | B | WT | ||||||||
DSY2251 | 16 | a/α | 1477-A | A | WT | |||||
1477-B | B | HYP | N972D | |||||||
E | CHUV | DSY544 | 0.5 | a/α | 1612-30 | A | WT | |||
1612-26 | B | WT | ||||||||
DSY775 | 128 | a/a | 1618-56 | A | HYP | G980W | ||||
F | CHUV | DSY1280 | 1 | a/α | 1635-4 | A | HYP | E461K | ||
1617-121 | B | HYP | E461K | |||||||
DSY1292 | 16 | a/α | 1490-A | A | A | HYP | N972S | |||
1490-C | A | B | HYP | N972S | ||||||
G | CHUV | DSY2242 | 8 | a/a | 1619-61 | B | HYP | G980E | ||
DSY2243 | 1 | a/a | 1637-3 | B | WT | |||||
H | CHUV | DSY555 | 8 | a/α | 1620-68 | A | WT | |||
1620-92 | B | HYP | R693K | |||||||
DSY556 | 128 | α/α | 1488-3 | A | HYP | R693K | ||||
DSY557 | 128 | α/α | 1493-12 | B | HYP | R693K | ||||
I | CHUV | DSY757 | 2 | a/α | 1623-83 | A | WT | |||
1623-82 | B | WT | ||||||||
DSY758 | 16 | a/α | 1624-86 | B | Allele A | HYP | A736V | |||
1624-88 | B | Allele B | HYP | A736V | ||||||
J | CHUV | DSY2260 | 8 | a/α | 1638-1 | A | HYP | E841Ga | ||
1638-3 | B | HYP | E841G | |||||||
DSY2262 | 64 | a/α | 1613-31 | A | A | HYP | E841G | |||
1639-1 | A | B | HYP | E841G | ||||||
K | CHUV | DSY482 | 8 | a/α | 1614-36 | B | WT | |||
1614-138 | A | WT | ||||||||
DSY488 | 16 | α/α | 1487-3 | A | HYP | A736T | ||||
L | CHUV | DSY520 | 32 | a/α | 1615-44 | A | WT | |||
1615-41 | B | HYP | N972D | |||||||
DSY522 | 128 | a/α | 1616-46 | B | HYP | N972D | ||||
1474-B | A | HYP | N972D | |||||||
M | CHUV | DSY2305 | 2 | a/α | 1633-3 | A | A | Allele A | WT | |
1633-4 | A | A | Allele B | WT | ||||||
DSY2306 | 8 | a/a | 1634-1 | A | From allele A | HYP | E461K | |||
N | CHUV | DSY2023 | 16 | α/α | 1528-10 | A | HYP | N972D | ||
DSY2025 | 16 | α/α | 1529-2 | A | HYP | N972D |
This putative GOF mutation was not verified by site-directed mutagenesis.
Only one TAC1 allele was cloned even if the sequence of the genomic DNA indicated a polymorphism at the MTL.
TAC1 sequence analysis was performed after failure of TAC1 allele discrimination by RFLP in MTL heterozygous strains.
CHUV, University Hospital Lausanne and University Hospital Center.
WT, wild type; HYP, hyperactive.